Written Question · S3W-40247 · Session 3
What guidance is provided to NHS boards regarding exceptional prescribing arrangements in relation to funding orphan and ultra-orphan medic…
The question
To ask the Scottish Executive what guidance is provided to NHS boards regarding exceptional prescribing arrangements in relation to funding orphan and ultra-orphan medicines not recommended by the Scottish Medicines Consortium.
The answer
The Scottish Government is developing national good practice guidance in relation to NHS boards management of individual patient treatment requests, previously known as exceptional prescribing requests, for all newly licensed medicines, including orphan medicines, that have not been recommended by the Scottish Medicines Consortium.
The guidance, which aims to support local decision-making on individual patient treatment requests through a consistent approach, will be published in due course.
The guidance, which aims to support local decision-making on individual patient treatment requests through a consistent approach, will be published in due course.
In the Official Report
No contribution in the Official Report cites S3W-40247 by reference.